Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New business development director at Movetis

This article was originally published in Scrip

Executive Summary

Movetis, a European speciality pharmaceutical company focused on gastrointestinal conditions with a high unmet medical need, has appointed Bjoern Peters as its new business development director. He joins from Intendis in Berlin, a daughter company of Bayer Healthcare, where for the past two years he was regional business director responsible for Asia-Pacific, North Europe, and the Middle East. He has also had several years' experience as business development manager in previous positions with Janssen-Cilag.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC000833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel